You run a European real-economy business with a real asset on the balance sheet: a warehouse, an energy installation, an equipment fleet, a receivables book. You need to raise capital against it. There are three honest options, and most of the noise in the market pretends there are more. Bank debt is the cheapest if you qualify and accept the constraints. Equity is the right tool if you want to sell part of the company. Tokenization sits between them: capital raised against a specific asset, without bank covenants and without selling your company. This guide compares the three on cost of capital, control, speed, and what each one actually demands of you as the operator, so you can decide which fits before the first investor conversation.
The mistake most owners make is treating capital as one decision: how do I get money. It is three decisions, and the three tools answer different ones. Bank debt answers "how do I borrow cheaply against an asset I am keeping." Equity answers "how do I sell part of my company to fund growth." Tokenization answers "how do I raise capital against a specific asset without selling the company or maxing out the bank." These are not competing answers to one question; they are answers to three different questions, and the right tool is the one whose question matches your situation.
This guide is written for the operator, not the investor. You are the one with the asset and the need for capital, deciding how to fund a raise. Most of what is written about tokenization is written for the investor deciding whether to buy in. This is the other side of the table: the business owner or CFO deciding whether tokenization is the right way to raise, compared honestly against the two options you already know.
The honest starting position is that tokenization is not always the answer. If a bank will lend you what you need against your asset at a rate you can live with, and you are comfortable with the covenants, take the bank debt. It is the cheapest cost of capital available. Tokenization earns its place specifically where bank debt does not fit (the amount, the asset type, the covenant load) and where you do not want to sell equity. Knowing when it does not fit is as important as knowing when it does, and an advisor who tells you tokenization is always the answer is selling, not advising.
What each option does to your cost of capital, your control, your timeline, and your balance sheet. The figures are indicative 2026 ranges for a mid-size European real-asset raise; your specifics will vary.
| Dimension | Bank debt | VC / private equity | Tokenization |
|---|---|---|---|
| What you sell | Nothing; you borrow | Part of the company | Fractional interests in one asset (via an SPV) |
| Cost of capital | Lowest (senior secured) | Highest (give up upside) | Between the two |
| Control | Kept, with covenants | Diluted; board seats, governance | Kept; investors own asset economics, not the company |
| Amount vs asset | Conservative LTV (often 50-65%) | Whatever the equity story supports | Can exceed bank LTV against the asset |
| Covenants | Yes; financial + operational | Shareholder agreement, reserved matters | SPV-level terms; no operating-company covenants |
| Speed to capital | Fastest with a relationship | Slowest (months of process) | ~3-6 months |
| Balance-sheet effect | Uses borrowing capacity | New shareholders permanently | Preserves borrowing capacity; off the operating balance sheet |
| Best when | Bank lends enough, clean asset, covenants acceptable | You want a partner and to sell the company's upside | Asset-rich, need more than the bank, want to keep the company |
The pattern across the table. Bank debt is cheapest but constrained: it caps the amount, takes covenants, and uses your borrowing capacity. Equity is the most flexible on amount but the most expensive in the long run because you give up the company's upside permanently. Tokenization is the middle path designed for a specific situation: an asset-rich business that needs more capital against an asset than a bank will lend, does not want to sell the company, and can accept a 3 to 6 month process and a cost of capital above senior debt. It is not cheaper than the bank and not more flexible than equity; it occupies the gap where neither of those fits.
If your business qualifies, senior secured bank debt is the cheapest capital you will find. A bank lends against your asset as collateral at a rate close to its cost of funds plus a margin, and you keep the asset and the company. For a clean asset with a creditworthy borrower, nothing beats it on cost.
What it costs you beyond the rate. The bank caps the loan at a conservative loan-to-value, often 50 to 65% of the asset's value, so you cannot raise the full value of the asset. It imposes covenants, financial ratios you must maintain and operational restrictions you must accept, and it uses your borrowing capacity, which means the next thing you want to fund competes with this loan for the same balance sheet. And the bank's appetite is conservative by design: it will lend against a stabilised, income-producing asset far more readily than against a value-add project, a development, or an asset with any complexity.
When bank debt is the right answer. When the amount you need is within what the bank will lend against the asset, the rate is acceptable, you are comfortable with the covenants, and you are happy to use the borrowing capacity for this. If all of those are true, take the bank debt and do not overthink it. This guide exists because for many asset-rich businesses, one or more of those is not true: the bank will not lend enough, the asset is too complex for the bank's appetite, the covenants are too restrictive, or the business wants to preserve its banking relationship and capacity for something else. Those are the situations where the other two options come into play.
Venture capital and private equity buy a piece of your company. In exchange for capital, you give up ownership, usually take on a board and reserved-matters rights, and accept the expectation of a liquidity event down the line. For the right business, this is a genuine partnership that brings capital, network, and credibility. For the wrong situation, it is the most expensive capital there is, because the price is a permanent share of everything the company becomes.
What it costs you beyond the dilution. Equity investors get governance: board seats, veto rights over major decisions, information rights, and a say in the company's direction. They expect growth and an exit, which shapes the company's strategy toward their timeline, not necessarily yours. And the dilution is permanent: a 25% stake sold today is 25% of the company forever, including the part of the value you create after they invest. For a business that is going to grow substantially, equity sold early is the most expensive capital of all in hindsight.
When equity is the right answer. When you want a partner, not just capital, when the business is a growth story that investors want to own a piece of, and when you are genuinely willing to sell part of the company and share its direction and upside. Equity fits high-growth businesses building toward an exit. It fits much less well for an established, asset-rich operating business that is profitable, wants growth capital against a specific asset, and does not want to give up control or a permanent share of the company. For that business, selling equity to fund an asset-level raise is using the most expensive tool for a job a cheaper one can do.
The core distinction: equity sells the company; tokenization sells a slice of one asset's economics. If your raise is about funding the company's overall growth and you want a partner, equity is a real option. If your raise is about getting capital against a specific valuable asset while keeping the company, tokenization is structurally the better fit, because it confines what the investor owns to the asset rather than the company.
Tokenization, for a real-economy business, is a way to raise capital against a specific asset by selling fractional interests in a special-purpose vehicle (SPV) that owns or holds the rights to that asset. The business contributes or sells the asset into the SPV, the SPV issues tokenized interests representing fractional ownership of the asset's economics, and qualified investors buy those interests. The capital raised goes to the business; the investors get the agreed share of the asset's cash flow.
The structural advantages over the other two options come from what the investor owns. They own a defined slice of one asset's economics, not the company. So the business keeps control of its operating company, keeps the upside of everything outside that one asset, and takes on no operating-company covenants. Compared to bank debt, tokenization can raise more against the asset than a conservative bank LTV and does not consume the company's borrowing capacity. Compared to equity, it does not dilute the company or give investors governance over the business. It is, in effect, asset-backed financing with a broader and more flexible investor base than a single bank, structured so the business keeps the wheel.
The business provides the asset and the diligence; the advisor and structuring team handle the rest. You need a real asset or cash flow that can be contractually defined, clean legal title or a clear path to it, and the willingness to go through institutional-grade due diligence on the asset, the operating track record, and the financials. The SPV setup, the legal wrapper, the tokenization platform, and the investor process are the structuring team's work. Your job is to provide the substance and cooperate with diligence; tokenization does not paper over a weak asset, it gives a strong one a capital path.
For the detail on what legal wrappers and jurisdictions are used, see the EU jurisdiction comparison guide; for which assets actually fit the tokenization stack, see the 12 RWAs that work guide; and for the full structural comparison to traditional private placement, see the tokenization vs private placement guide.
Tokenization is not a tool for a pre-revenue business with no assets. It is not a way to raise against a story or a projection with nothing real underneath. And it is not magic that turns a weak asset into a fundable one. It is asset-backed capital for a real asset, and it works to exactly the extent the underlying asset is real, documentable, and cash-flow-producing. A business with a 15 million euro warehouse, a 10 million euro energy installation, or a 20 million euro receivables book is a candidate. A business with an idea and no asset is not.
If you run a real-economy business with a €5M+ asset or revenue base and you are weighing how to fund a raise, a strategy call is the fastest way to see whether tokenization fits, where it does not, and what the structure and path would look like for your specific asset. No pitch, no obligation.
Book a tokenization strategy call →The headline rate is not the cost of capital. A bank loan's headline rate looks cheapest, but the true cost includes the constraint on how much you can raise, the covenant load, and the borrowing capacity consumed. Equity has no headline rate at all, but its true cost is the permanent share of the company's future. Tokenization's cost is the investor yield plus the setup, but it does not constrain the company or dilute it. To compare honestly, you have to look at all-in cost for the capital you actually need, not the sticker rate.
Lowest nominal cost, but if the bank will only lend 60% of the asset and you need 90%, the bank's cheap rate solves only two-thirds of your problem. The effective cost of "the capital you actually need" has to account for the part the bank will not provide, which you then fund more expensively elsewhere.
No interest, but you have sold a permanent share of the company. If the business doubles in value after the raise, the equity investor's share doubled too, and that gain is the real cost of the capital. For a growing business, equity sold to fund an asset-level need is usually the most expensive option in hindsight, precisely because the company grew.
You pay investors a yield on the tokenized interests (typically high single digits to mid-teens gross depending on asset and risk, sitting above senior debt because investors take more risk than a secured bank, and below equity because they do not get the company's upside), plus the one-off setup cost amortised over the raise. But you keep the company, keep the borrowing capacity, and do not dilute. For a raise above what the bank will lend on an asset you want to keep in a company you do not want to sell, the all-in cost is frequently better than the equity alternative and accessible where the bank is not. The full gross-to-net economics of what the investor side looks like, which determines the yield you have to offer, is in the yield cascade guide.
The comparison that matters: not "which has the lowest rate" but "which delivers the capital I actually need at the lowest all-in cost, given what I am willing to give up." Bank debt wins on rate but loses on amount and constraint. Equity wins on amount but loses on permanent cost and control. Tokenization wins specifically when you need more than the bank will give against an asset you want to keep, without selling the company. Run the all-in number for your real situation, not the sticker rates.
The decision reduces to three questions, in order.
Most asset-rich European real-economy businesses raising 3 to 30 million euros that reach the third question (the bank will not do it at the size they need, and they do not want to sell equity) are looking at tokenization for exactly the reasons it exists: it fills the gap between debt and equity for an asset-backed raise. The businesses for which it does not fit are the ones the bank serves well, the ones genuinely raising company equity for a growth partnership, and the ones with no real asset to raise against. Knowing which of those you are is the whole decision.
For the broader picture of what a tokenization advisor actually does in a raise, see the what a tokenization advisor does guide; for how to evaluate and choose one, see the find a tokenization advisor guide; and the tokenize your business guide walks the operator-side process end to end.
Bring the asset, the amount, and the constraint you are running into with the bank or with equity. A strategy call walks the three options against your specific situation: whether tokenization fits, where it does not, the structure and timeline, and the honest all-in cost compared to the alternatives. For real-economy businesses with €5M+ in revenue or assets. No pitch, no obligation.
Not on the headline rate, and that is the wrong comparison. Bank debt is the cheapest nominal cost if you qualify, but it caps the amount at a conservative LTV, takes covenants, and uses your borrowing capacity. Tokenization costs more per euro but can raise more against the asset, takes no operating-company covenants, and preserves your bank capacity. Compare all-in cost for the capital you actually need, not sticker rates. See section 06.
Equity sells a piece of the company; tokenization sells a piece of one asset's economics via an SPV. With equity you dilute, take a board, and share the company's upside permanently. With tokenization you keep the company and control, and investors own the asset's cash flow, not the business. See section 04 and section 05.
An asset-rich European real-economy business with a real asset or predictable cash flow worth ~€5M+: industrial/commercial property, energy operators, infrastructure, equipment leasing, receivables books. The asset must produce a definable cash flow, be large enough to justify the overhead, and fit a standardised wrapper. A business with no real asset does not fit. See section 05.
Two layers: setup (legal, SPV, platform, advisory, ongoing admin, typically tens to low hundreds of thousands depending on jurisdiction and size) and cost of capital (the investor yield, high single digits to mid-teens gross by asset and risk). Compare the all-in figure against the bank or equity alternative. See section 06.
Roughly 3-6 months from decision to capital: structuring (6-12 weeks), offering preparation, and placement. Longer than a bank loan with a relationship, shorter than most equity processes. If you need capital next month, use your bank.
No. Investors buy interests in the SPV that holds the asset, not in your operating company. You keep ownership and control of the company and often keep operating the asset under a management agreement. That is the structural difference from equity. See section 05.
The asset and the diligence: a real, documentable, cash-flow-producing asset, clean title or a clear path to it, historical financials, operating data, and cooperation with institutional-grade due diligence. The structuring team handles the SPV, wrapper, tokenization, and investor process. Tokenization does not fix a weak asset; it gives a strong one a capital path.
Three questions: (1) will a bank lend what you need on acceptable terms? Take it if yes. (2) Do you want to sell part of the company? Equity if yes. (3) Asset-rich, need more than the bank, want to keep the company? That is the tokenization case. See section 07.
A tokenization strategy call walks your specific asset and raise against the three options honestly, including where tokenization does not fit. The advisor page sets out how an engagement works.